
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Uric Acid and Cardiovascular Risk
Daniel I. Feig, Duk‐Hee Kang, Richard J. Johnson
New England Journal of Medicine (2008) Vol. 359, Iss. 17, pp. 1811-1821
Open Access | Times Cited: 2268
Daniel I. Feig, Duk‐Hee Kang, Richard J. Johnson
New England Journal of Medicine (2008) Vol. 359, Iss. 17, pp. 1811-1821
Open Access | Times Cited: 2268
Showing 26-50 of 2268 citing articles:
Common Defects of ABCG2, a High-Capacity Urate Exporter, Cause Gout: A Function-Based Genetic Analysis in a Japanese Population
Hirotaka Matsuo, Tappei Takada, Kimiyoshi Ichida, et al.
Science Translational Medicine (2009) Vol. 1, Iss. 5
Closed Access | Times Cited: 402
Hirotaka Matsuo, Tappei Takada, Kimiyoshi Ichida, et al.
Science Translational Medicine (2009) Vol. 1, Iss. 5
Closed Access | Times Cited: 402
Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions
Justin C. Mason, Peter Libby
European Heart Journal (2014) Vol. 36, Iss. 8, pp. 482-489
Open Access | Times Cited: 390
Justin C. Mason, Peter Libby
European Heart Journal (2014) Vol. 36, Iss. 8, pp. 482-489
Open Access | Times Cited: 390
The Biological Relevance of Direct Antioxidant Effects of Polyphenols for Cardiovascular Health in Humans Is Not Established1–4
P.C.H. Hollman, Aedín Cassidy, Blandine Comte, et al.
Journal of Nutrition (2011) Vol. 141, Iss. 5, pp. 989S-1009S
Open Access | Times Cited: 388
P.C.H. Hollman, Aedín Cassidy, Blandine Comte, et al.
Journal of Nutrition (2011) Vol. 141, Iss. 5, pp. 989S-1009S
Open Access | Times Cited: 388
Cardiorenal Syndrome Type 1
Claudio Ronco, Mariantonietta Cicoira, Peter A. McCullough
Journal of the American College of Cardiology (2012) Vol. 60, Iss. 12, pp. 1031-1042
Closed Access | Times Cited: 377
Claudio Ronco, Mariantonietta Cicoira, Peter A. McCullough
Journal of the American College of Cardiology (2012) Vol. 60, Iss. 12, pp. 1031-1042
Closed Access | Times Cited: 377
The Effects of Salsalate on Glycemic Control in Patients With Type 2 Diabetes
Allison B. Goldfine
Annals of Internal Medicine (2010) Vol. 152, Iss. 6, pp. 346-346
Open Access | Times Cited: 375
Allison B. Goldfine
Annals of Internal Medicine (2010) Vol. 152, Iss. 6, pp. 346-346
Open Access | Times Cited: 375
Update on gout: new therapeutic strategies and options
Robert Terkeltaub
Nature Reviews Rheumatology (2010) Vol. 6, Iss. 1, pp. 30-38
Closed Access | Times Cited: 371
Robert Terkeltaub
Nature Reviews Rheumatology (2010) Vol. 6, Iss. 1, pp. 30-38
Closed Access | Times Cited: 371
Effects of Thyroid Dysfunction on Lipid Profile
Christos V. Rizos
The Open Cardiovascular Medicine Journal (2011) Vol. 5, Iss. 1, pp. 76-84
Open Access | Times Cited: 362
Christos V. Rizos
The Open Cardiovascular Medicine Journal (2011) Vol. 5, Iss. 1, pp. 76-84
Open Access | Times Cited: 362
Uric acid, hyperuricemia and vascular diseases
Ming Jin, Fan Yang, Irene Yang, et al.
Frontiers in bioscience (2011) Vol. 17, Iss. 1, pp. 656-656
Open Access | Times Cited: 359
Ming Jin, Fan Yang, Irene Yang, et al.
Frontiers in bioscience (2011) Vol. 17, Iss. 1, pp. 656-656
Open Access | Times Cited: 359
Empagliflozin as Add-on to Metformin Plus Sulfonylurea in Patients With Type 2 Diabetes
Hans‐Ulrich Häring, Ludwig Merker, Elke Seewaldt-Becker, et al.
Diabetes Care (2013) Vol. 36, Iss. 11, pp. 3396-3404
Open Access | Times Cited: 347
Hans‐Ulrich Häring, Ludwig Merker, Elke Seewaldt-Becker, et al.
Diabetes Care (2013) Vol. 36, Iss. 11, pp. 3396-3404
Open Access | Times Cited: 347
Uric acid and evolution
Bonifacio Álvarez-Lario, Jesús Macarrón‐Vicente
Lara D. Veeken (2010) Vol. 49, Iss. 11, pp. 2010-2015
Closed Access | Times Cited: 346
Bonifacio Álvarez-Lario, Jesús Macarrón‐Vicente
Lara D. Veeken (2010) Vol. 49, Iss. 11, pp. 2010-2015
Closed Access | Times Cited: 346
Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels
Adrienne Tin, Jonathan Marten, Victoria L. Halperin Kuhns, et al.
Nature Genetics (2019) Vol. 51, Iss. 10, pp. 1459-1474
Open Access | Times Cited: 336
Adrienne Tin, Jonathan Marten, Victoria L. Halperin Kuhns, et al.
Nature Genetics (2019) Vol. 51, Iss. 10, pp. 1459-1474
Open Access | Times Cited: 336
Skin-Interfaced Wearable Sweat Sensors for Precision Medicine
Jihong Min, Jiaobing Tu, Changhao Xu, et al.
Chemical Reviews (2023) Vol. 123, Iss. 8, pp. 5049-5138
Open Access | Times Cited: 332
Jihong Min, Jiaobing Tu, Changhao Xu, et al.
Chemical Reviews (2023) Vol. 123, Iss. 8, pp. 5049-5138
Open Access | Times Cited: 332
Uric Acid Reduction Rectifies Prehypertension in Obese Adolescents
Beth Soletsky, Daniel I. Feig
Hypertension (2012) Vol. 60, Iss. 5, pp. 1148-1156
Open Access | Times Cited: 319
Beth Soletsky, Daniel I. Feig
Hypertension (2012) Vol. 60, Iss. 5, pp. 1148-1156
Open Access | Times Cited: 319
Hyperuricemia and Risk of Incident Hypertension: A Systematic Review and Meta-Analysis of Observational Studies
Ji Wang, Tianqiang Qin, Jianrong Chen, et al.
PLoS ONE (2014) Vol. 9, Iss. 12, pp. e114259-e114259
Open Access | Times Cited: 315
Ji Wang, Tianqiang Qin, Jianrong Chen, et al.
PLoS ONE (2014) Vol. 9, Iss. 12, pp. e114259-e114259
Open Access | Times Cited: 315
Multiple Genetic Loci Influence Serum Urate Levels and Their Relationship With Gout and Cardiovascular Disease Risk Factors
Qiong Yang, Anna Köttgen, Abbas Dehghan, et al.
Circulation Cardiovascular Genetics (2010) Vol. 3, Iss. 6, pp. 523-530
Open Access | Times Cited: 313
Qiong Yang, Anna Köttgen, Abbas Dehghan, et al.
Circulation Cardiovascular Genetics (2010) Vol. 3, Iss. 6, pp. 523-530
Open Access | Times Cited: 313
Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial
Kenjiro Kimura, Tatsuo Hosoya, Shunya Uchida, et al.
American Journal of Kidney Diseases (2018) Vol. 72, Iss. 6, pp. 798-810
Open Access | Times Cited: 310
Kenjiro Kimura, Tatsuo Hosoya, Shunya Uchida, et al.
American Journal of Kidney Diseases (2018) Vol. 72, Iss. 6, pp. 798-810
Open Access | Times Cited: 310
Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options
Thomas Bardin, Pascal Richette
BMC Medicine (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 308
Thomas Bardin, Pascal Richette
BMC Medicine (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 308
Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies
Xue Li, Xiangrui Meng, Maria Timofeeva, et al.
BMJ (2017), pp. j2376-j2376
Open Access | Times Cited: 301
Xue Li, Xiangrui Meng, Maria Timofeeva, et al.
BMJ (2017), pp. j2376-j2376
Open Access | Times Cited: 301
NLRP3 at the interface of metabolism and inflammation
Moritz Haneklaus, Luke O'neill
Immunological Reviews (2015) Vol. 265, Iss. 1, pp. 53-62
Closed Access | Times Cited: 273
Moritz Haneklaus, Luke O'neill
Immunological Reviews (2015) Vol. 265, Iss. 1, pp. 53-62
Closed Access | Times Cited: 273
A Systematic Comparison of the Properties of Clinically Used Angiotensin II Type 1 Receptor Antagonists
Martin C. Michel, Carolyn Foster, Hans R. Brunner, et al.
Pharmacological Reviews (2013) Vol. 65, Iss. 2, pp. 809-848
Closed Access | Times Cited: 271
Martin C. Michel, Carolyn Foster, Hans R. Brunner, et al.
Pharmacological Reviews (2013) Vol. 65, Iss. 2, pp. 809-848
Closed Access | Times Cited: 271
SGLT2 Inhibitors and Cardiovascular Risk: Lessons Learned From the EMPA-REG OUTCOME Study
Muhammad Abdul‐Ghani, Stefano Del Prato, Robert Ćhilton, et al.
Diabetes Care (2016) Vol. 39, Iss. 5, pp. 717-725
Open Access | Times Cited: 268
Muhammad Abdul‐Ghani, Stefano Del Prato, Robert Ćhilton, et al.
Diabetes Care (2016) Vol. 39, Iss. 5, pp. 717-725
Open Access | Times Cited: 268
Sugar-sweetened beverages and risk of hypertension and CVD: a dose–response meta-analysis
Bo Xi, Yubei Huang, Kathleen H. Reilly, et al.
British Journal Of Nutrition (2015) Vol. 113, Iss. 5, pp. 709-717
Open Access | Times Cited: 260
Bo Xi, Yubei Huang, Kathleen H. Reilly, et al.
British Journal Of Nutrition (2015) Vol. 113, Iss. 5, pp. 709-717
Open Access | Times Cited: 260
Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD
Anand Srivastava, Arnaud D. Kazé, Ciaran J. McMullan, et al.
American Journal of Kidney Diseases (2017) Vol. 71, Iss. 3, pp. 362-370
Open Access | Times Cited: 259
Anand Srivastava, Arnaud D. Kazé, Ciaran J. McMullan, et al.
American Journal of Kidney Diseases (2017) Vol. 71, Iss. 3, pp. 362-370
Open Access | Times Cited: 259
Gout: why is this curable disease so seldom cured?
Michael Doherty, Tim Jansen, George Nuki, et al.
Annals of the Rheumatic Diseases (2012) Vol. 71, Iss. 11, pp. 1765-1770
Closed Access | Times Cited: 257
Michael Doherty, Tim Jansen, George Nuki, et al.
Annals of the Rheumatic Diseases (2012) Vol. 71, Iss. 11, pp. 1765-1770
Closed Access | Times Cited: 257
Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: A meta-analysis of prospective studies
Gang Zhao, Lan Huang, Mingbao Song, et al.
Atherosclerosis (2013) Vol. 231, Iss. 1, pp. 61-68
Closed Access | Times Cited: 255
Gang Zhao, Lan Huang, Mingbao Song, et al.
Atherosclerosis (2013) Vol. 231, Iss. 1, pp. 61-68
Closed Access | Times Cited: 255